Financhill
Back

Credit Suisse Asset Management Income Fund Inc. Vs. CRISPR Therapeutics AG Industry Stock Comparison

Sell
40

CIK
Credit Suisse Asset Management Income Fund Inc.

Last Price:
$2.82
Seasonality Move:
2.58%
Sell
43

CRSP
CRISPR Therapeutics AG

Last Price:
$55.85
Seasonality Move:
14.46%
Sell
40
Credit Suisse Asset Management Income Fund Inc. (CIK) is a Sell

Is Credit Suisse Asset Management Income Fund Inc. a Buy, Sell or Hold?

  • The current Credit Suisse Asset Management Income Fund Inc. [CIK] share price is $2.82. The Score for CIK is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • CIK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $55.86. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CIK Stock Price Chart

What is Credit Suisse Asset Management Income Fund Inc.'s stock price today?

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $55.86
    The current trend is relatively stagnant and CRSP is experiencing slight buying pressure.

CIK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 49.69 Sell
Chaikin Money Flow: 314437 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.79 - 2.83) Buy
Bollinger Bands (100): (2.82 - 2.98) Sell

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 49.16 Sell
Chaikin Money Flow: 78181 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.94 - 57.06) Buy
Bollinger Bands (100): (52.44 - 65.4) Sell

CIK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.81 Buy
20-day SMA: 2.81 Buy
50-day SMA: 2.84 Sell
200-day SMA: 2.89 Sell
8-day EMA: 2.81 Buy
20-day EMA: 2.82 Buy
50-day EMA: 2.84 Sell
200-day EMA: 2.9 Sell

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.25 Sell
20-day SMA: 55.05 Buy
50-day SMA: 58.96 Sell
200-day SMA: 51.1 Buy
8-day EMA: 55.79 Buy
20-day EMA: 55.79 Buy
50-day EMA: 56.36 Sell
200-day EMA: 37.56 Buy

Credit Suisse Asset Management Income Fund Inc. Earnings Growth & CIK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.

Credit Suisse Asset Management Income Fund Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):